SGX IPO Revival
Singapore Exchange divests Scientific Beta to focus on a surging IPO pipeline, even as Foundation Healthcare shares tumble below offer price on debut.
Get a push when something new happens here — high-importance only.
- Velocity3.0/day
- Sources0
- Markets2
- MARKETFoundation Healthcare shares fall 7.9% below IPO price on SGX debut
The Singapore-listed healthcare provider ended its first day of trading significantly lower than the offer price, reversing an initial modest gain and testing early investor confidence.
- STATEMENTLiaw
“We want to provide insurance companies and consumers transparency in cost and medical outcome,”
in: Foundation Healthcare shares fall 7.9% below IPO price on SGX debut - STATEMENTLiaw
“If you gain the trust from the insurance companies and patients, insurance companies will favour you and that's how we should grow revenue.”
in: Foundation Healthcare shares fall 7.9% below IPO price on SGX debut - MARKETFoundation Healthcare opens 0.7% above IPO price on SGX debut
The healthcare provider's modest gain on its first day of trading follows a public offer that was 3.8 times subscribed at 76 cents a share.
- MARKETSingapore IPO pipeline reactivates as new listings hit SGX
A fresh wave of initial public offerings landed on the Singapore Exchange on Tuesday, signaling that government revitalization measures are beginning to restore listing momentum after a prolonged period of subdued activity.